Department of Periodontology, Universitat Internacional de Catalunya, C/ Josep Trueta s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain.
Department of Oral Surgery, Universitat Internacional de Catalunya, Barcelona, Spain.
Clin Oral Investig. 2018 Mar;22(2):555-570. doi: 10.1007/s00784-017-2301-1. Epub 2018 Jan 8.
The aim of this article is to systematically review the effect of subcrestal implant placement compared with equicrestal position on hard and soft tissues around dental implants with platform switch.
A manual and electronic search (National Library of Medicine and Cochrane Central Register of Controlled Trials) was performed for animal and human studies published up to December 2016. Primary outcome variable was marginal bone level (MBL) and secondary outcomes were crestal bone level (CBL), soft tissue dimensions (barrier epithelium, connective tissue, and peri-implant mucosa), and changes in the position of soft tissue margin. For primary and secondary outcomes, data reporting mean values and standard deviations of each study were extracted and weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated.
A total of 14 publications were included (7 human studies and 7 animal investigations). The results from the meta-analyses have shown that subcrestal implants, when compared with implants placed in an equicrestal position, exhibited less MBL changes (human studies: WMD = - 0.18 mm; 95% CI = - 1.31 to 0.95; P = 0.75; animal studies: WMD = - 0.45 mm; 95% CI = - 0.66 to - 0.24; P < 0.001). Furthermore, the CBL was located at a more coronal position in subcrestal implants with respect to the implant shoulder (WMD = - 1.09 mm; 95% CI = - 1.43 to - 0.75; P < 0.001). The dimensions of the peri-implant mucosa seem to be affected by the positioning of the microgap and were greater at implants placed in a subcrestal position than those inserted equicrestally (WMD = 0.60 mm; 95% CI = 0.26 to 0.95; P < 0.001). While the length of the barrier epithelium was significantly greater in implants placed in a subcrestal position (WMD = 0.39 mm; 95% CI = 0.19 to 0.58; P < 0.001), no statistical significant differences were observed between equicrestal and subcrestal implant positioning for the connective tissue length (WMD = 0.17 mm; 95% CI = - 0.03 to 0.36; P = 0.10).
This systematic review suggests that PS implants placed in a subcrestal position have less MBL changes when compared with implants placed equicrestally. Furthermore, the location of the microgap seems to have an influence on the dimensions of peri-implant soft tissues. Clinical relevance When compared with PS placed in an equicrestal position, subcrestal implant positioning demonstrated less peri-implant bone remodeling.
本文旨在系统地回顾平台转换后种植体在骨下植入与在平齐植入位置对种植体周围软硬组织的影响。
对截至 2016 年 12 月的动物和人类研究进行了手动和电子搜索(国家医学图书馆和 Cochrane 对照试验中心注册)。主要结局变量为边缘骨水平(MBL),次要结局变量为嵴顶骨水平(CBL)、软组织维度(屏障上皮、结缔组织和种植体周围黏膜)以及软组织边缘位置的变化。对于主要和次要结局,提取报告每项研究均值和标准差的数据,并计算加权均数差(WMD)和 95%置信区间(CI)。
共纳入 14 项研究(7 项人类研究和 7 项动物研究)。荟萃分析结果表明,与平齐植入位置相比,骨下植入的种植体 MBL 变化较小(人类研究:WMD=-0.18mm;95%CI=-1.31 至 0.95;P=0.75;动物研究:WMD=-0.45mm;95%CI=-0.66 至 -0.24;P<0.001)。此外,与种植体肩部相比,骨下植入的 CBL 位于更冠方的位置(WMD=-1.09mm;95%CI=-1.43 至 -0.75;P<0.001)。种植体周围黏膜的维度似乎受到微间隙定位的影响,与平齐植入位置相比,骨下植入的种植体周围黏膜更大(WMD=0.60mm;95%CI=0.26 至 0.95;P<0.001)。而屏障上皮的长度在骨下植入位置显著更大(WMD=0.39mm;95%CI=0.19 至 0.58;P<0.001),但平齐和骨下植入位置之间的结缔组织长度无统计学差异(WMD=0.17mm;95%CI=-0.03 至 0.36;P=0.10)。
本系统评价表明,与平齐植入相比,PS 植入体在骨下植入位置时 MBL 变化较小。此外,微间隙的位置似乎对种植体周围软组织的维度有影响。
与平齐 PS 植入位置相比,骨下植入位置的种植体周围骨重塑较少。